Research Day Agenda

Sidebar

Annual CFAR HIV Research Day

Tuesday, October 18, 2016
Medical Education and Telemedicine Building
UC San Diego, La Jolla, California 

Time Topic Speaker
8:30
am
Greetings and introduction Douglas D. Richman, MD
8:35
am
Keynote address: The state of the HIV pandemic: 
Where are we now?
Steffanie Strathdee, PhD
Session 1: Moderator--Emila Noormahomed, MD, PhD
9:35
am
Characteristics associated with fluid responsiveness and fluid toxicity demonstrated by passive leg raise maneuver in septic patients in a Mozambican Emergency Department Lucia Chambal, MD
9:55
am
Attitudes toward biomedicine and HIV-related knowledge among Mozambican traditional healers: Preliminary results from a qualitative study Radhika Sundararajan, 
MD, PhD
10:15 am Screening and treatment for latent tuberculosis infection of health workers at Maputo Central Hospital, the National Reference Hospital of Mozambique Pereira Zindoga, MD
10:35
am
Latent tuberculosis infection among persons with HIV in Tijuana, Baja California Fátima Muñoz, MD, MPH
Session 2: Moderator--Natasha Martin, PhD
11:05
am
CFAR Core Services: Clinical Investigation and Biostatistical and Modeling Cores Maile Karris, MD
Natasha Martin, PhD
Sonia Jain, PhD
11:15
am
Modeling the potential impact of incarceration on HIV incidence among people who inject drugs in Tijuana, Mexico Annick Borquez, MSc, PhD
11:35
am
Migration and HIV transmission in Mesoamerica Antoine Chaillon, MD, PhD
11:55
am
HIV transmission dynamics in Tijuana, Mexico: Real-time identification of a new transmission cluster Sanjay Mehta, MD
12:15
pm
Country differences in substance use among HIV-positive Latinos in the U.S. - Mexico border region Nicole Pepper, MSSW
Session 3: Moderator--Charles Hicks, MD
1:15
pm
Pre-Exposure Prophylaxis (PrEP) accessibility research and evaluation 2 (PrEPARE2): HIV risk perception among men who have sex with men (MSM) Evan Mulvihill, PharmD Candidate 2018
1:35
pm
Management of HIV-infected patients following HIV archive DNA genotype testing Helen King, MD
1:55
pm
Does disease progression potentiate the effects of polytobacco use? A characterization of intention to quit among newly diagnosed HIV seropositive smokers Micah Savin
2:15
pm
Closing remarks Davey Smith, MD, MAS

At a Glance